fatty-liver

Documents about fatty-liver

• A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease#876213ClinicalTrials.gov
• Fatty Liver and Pancreatic Steatosis#854129ClinicalTrials.gov
• Metformin in Non-Alcoholic Fatty Liver Disease#238311ClinicalTrials.gov
• Effect of Sodium Glucose Cotransporter Inhibitors Fatty Liver Disease Patients Fatigue Assessment#1010169ClinicalTrials.gov
• Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease#1010941ClinicalTrials.gov
• Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)#394736ClinicalTrials.gov
• Fatty Liver Imaging Project ( FLIP ) Patient Pilot Study#859015ClinicalTrials.gov
• A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease#859439ClinicalTrials.gov
• Intermittent Fasting for NAFLD in Adults#979707ClinicalTrials.gov
• Rifaximin in Fatty Liver Disease#158000ClinicalTrials.gov
• Fatty Liver Patient Registry#967073ClinicalTrials.gov
• the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.#868022ClinicalTrials.gov
• Anti-diabetic Drugs and Fatty Liver Management#391065ClinicalTrials.gov
• Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients#435708ClinicalTrials.gov
• Lifestyle Intervention in Fatty Liver (NAFLD)#851956ClinicalTrials.gov
• The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease#843881ClinicalTrials.gov
• Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease#861380ClinicalTrials.gov
• Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease#471566ClinicalTrials.gov
• Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver#804412ClinicalTrials.gov
• A Pilot Study to Explore the Role of Gut Flora in Fatty Liver#995294ClinicalTrials.gov
• Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids#802894ClinicalTrials.gov
• Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease#863709ClinicalTrials.gov
• A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis#867239ClinicalTrials.gov
• The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients#992511ClinicalTrials.gov
• Identification and Characterization of NAFLD in Turkey#287436ClinicalTrials.gov
• Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus Atorvastatin#325266ClinicalTrials.gov
• Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus#854398ClinicalTrials.gov
• Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy#855911ClinicalTrials.gov
• Diabetes, Exercise and Liver Fat (DELIVER)#843590ClinicalTrials.gov
• Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression#840137ClinicalTrials.gov
• Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver Disease#847295ClinicalTrials.gov
• Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity#912570ClinicalTrials.gov
• Effect of Probiotic and Smectite Gel on NAFLD#417488ClinicalTrials.gov
• A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease#123655ClinicalTrials.gov
• Curcumin Supplement in Nonalcoholic Fatty Liver Patients#127760ClinicalTrials.gov
• Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver Disease#303683ClinicalTrials.gov
• Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease#373731ClinicalTrials.gov
• Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes#859282ClinicalTrials.gov
• Ketotifen in Non-Alcoholic Fatty Liver Disease Patients#900161ClinicalTrials.gov
• The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease#982384ClinicalTrials.gov
• Perirenal Fats of Chronic Kidney Disease in Patients With Fatty Liver Disease.#803210ClinicalTrials.gov
• Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease#842659ClinicalTrials.gov
• The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease#833536ClinicalTrials.gov
• Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease#846054ClinicalTrials.gov
• Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease#383649ClinicalTrials.gov
• Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)#651226ClinicalTrials.gov
• The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease#896820ClinicalTrials.gov
• High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease#901341ClinicalTrials.gov
• 2-Week Study In People With Nonalcoholic Fatty Liver Disease#904649ClinicalTrials.gov
• Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis#807114ClinicalTrials.gov